← Leaderboards
Ning Jenny Jiang
Stanford University
$4,672,500
Attributed
$7,651,654
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,651,654 · 7
By mechanism
RF1$3,213,011 · 1
R33$2,243,316 · 2
R00$739,529 · 1
R56$699,999 · 1
S10$489,417 · 1
K99$266,382 · 1
Top collaborators
- Amy Brock3 shared
- Wassim Elyaman1 shared
- Neil Alan Shneider1 shared
- Lawrence J Stern1 shared
Most similar at Stanford University
Same institution · by research overlap
- Brent T Harris$9,207,569
- Andrew Z. Fire$18,212,138
- Samuel Strober$36,157,957
- Cornelia L Dekker$13,121,812
- Mark M Davis$39,722,191
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-Cell ReceptorT-LymphocyteTechnologyLibrariesBaseGene ExpressionLinkImmune System DiseasesInfectionBlood DonorImmunePeripheral BloodGenesEpitopesImmune ResponseGenomicsAntigensSurfaceActivities Of Daily LivingPhenotypeElderlyCytomegalovirus InfectionsMalignant Neoplasms
Grant awards (17)
Characterization of Antigen-Specific Immune Response in ALS$3,213,011
RF1 · FY2025 · NS
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$370,830
R33 · FY2023 · CA · contact PI
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$373,068
R33 · FY2022 · CA · contact PI
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer$335,237
R33 · FY2022 · CA · contact PI
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$394,894
R33 · FY2021 · CA · contact PI
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer$359,555
R33 · FY2020 · CA · contact PI
An integrated approach to T cell repertoire in aging$349,999
R56 · FY2020 · AG · contact PI
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer$12,773
R33 · FY2020 · CA · contact PI
An integrated approach to T cell repertoire in aging$350,000
R56 · FY2019 · AG · contact PI
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer$396,959
R33 · FY2018 · CA · contact PI
BioMark HD System for High-Throughput Genomic Studies$489,417
S10 · FY2015 · OD · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$241,529
R00 · FY2015 · AG · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$249,000
R00 · FY2014 · AG · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$249,000
R00 · FY2013 · AG · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$133,191
K99 · FY2012 · AG · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$104,975
K99 · FY2011 · AG · contact PI
Genomic Approaches to the T Cell Receptor Repertoire during Aging$28,216
K99 · FY2011 · AG · contact PI